Location: New York, NY
CIK: 0001482416 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 13, 2023
Total Value: $270M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| — | PROMETHEUS BIOSCIENCES INC | 574,200 | $63.16M | 23.4% | $110.00 | — | — | Put | 74349U108 |
| — | MEDICUS SCIENCES ACQUISITION | 2,323,000 | $23.39M | 8.7% | $10.07 | $9.72 | — | CL A SHS | G5960S108 |
| BCYC | BICYCLE THERAPEUTICS PLC | 683,425 | $20.23M | 7.5% | $29.60 | $20.16 | — | SPONSORED ADS | 088786108 |
| CI | CIGNA CORP | 52,611 | $17.43M | 6.4% | $331.34 * | $187.09 | +59.7% | COM | 125523100 |
| OGN | ORGANON & CO | 587,836 | $16.42M | 6.1% | $27.93 * | $29.18 | -24.7% | COMMON STOCK | 68622V106 |
| UTHR | UNITED THERAPEUTICS CORP | 54,959 | $15.28M | 5.7% | $278.09 * | $165.91 | +52.2% | COM | 91307C102 |
| DGX | QUEST DIAGNOSTICS INC | 92,000 | $14.39M | 5.3% | $156.44 | — | — | Put | 74834L100 |
| COR | AMERISOURCEBERGEN CORP | 84,399 | $13.99M | 5.2% | $165.71 * | $135.64 | +13.1% | COM | 03073E105 |
| MDT | MEDTRONIC PLC | 128,000 | $9.948M | 3.7% | $77.72 * | $73.46 | 0.0% | SHS | G5960L103 |
| STAA | STAAR SURGICAL CO | 157,129 | $7.627M | 2.8% | $48.54 * | $62.72 | 0.0% | COM PAR $0.01 | 852312305 |
| ICLR | ICON PLC | 33,983 | $6.601M | 2.4% | $194.25 * | $198.26 | 0.0% | SHS | G4705A100 |
| INGN | INOGEN INC | 286,692 | $5.651M | 2.1% | $19.71 * | $31.10 | -30.8% | COM | 45780L104 |
| AVTR | AVANTOR INC | 250,000 | $5.272M | 1.9% | $21.09 | $20.70 | 0.0% | COM | 05352A100 |
| — | HESKA CORP | 84,309 | $5.241M | 1.9% | $62.16 | $62.16 | — | COM RESTRC NEW | 42805E306 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 434,635 | $4.742M | 1.8% | $10.91 * | $8.44 | 0.0% | COM | 74366E102 |
| NVAX | NOVAVAX INC | 340,000 | $3.495M | 1.3% | $10.28 * | $17.65 | 0.0% | COM NEW | 670002401 |
| — | CYMABAY THERAPEUTICS INC | 555,610 | $3.484M | 1.3% | $6.27 | $3.37 | — | COM | 23257D103 |
| PHVS | PHARVARIS NV | 285,000 | $3.206M | 1.2% | $11.25 * | $5.25 | 0.0% | COM | N69605108 |
| — | MERRIMACK PHARMACEUTICALS INC | 250,000 | $2.865M | 1.1% | $11.46 | $11.46 | — | COM NEW | 590328209 |
| — | REATA PHARMACEUTICALS INC | 67,000 | $2.545M | 0.9% | $37.99 | — | — | Put | 75615P103 |
| — | HEALTH SCIENCES ACQUISITIONS CORP 2 | 250,000 | $2.495M | 0.9% | $9.98 | $11.00 | — | ORD SHS | G4411D109 |
| — | EUCRATES BIOMEDICAL ACQUISITION CORP. | 248,674 | $2.482M | 0.9% | $9.98 | $10.66 | — | UNIT 10/23/2027 | G3141W114 |
| — | CTI BIOPHARMA CORP | 330,000 | $1.983M | 0.7% | $6.01 | $6.01 | — | COM | 12648L601 |
| — | IVERIC BIO INC | 86,400 | $1.85M | 0.7% | $21.41 | — | — | Put | 46583P102 |
| — | X4 PHARMACEUTICALS INC | 1,825,963 | $1.813M | 0.7% | $0.99 | $2.60 | — | COM | 98420X103 |
| MODD | MODULAR MEDICAL INC | 689,352 | $1.379M | 0.5% | $2.00 * | $4.31 | -30.1% | COM NEW | 60785L207 |
| — | MERUS NV | 87,953 | $1.361M | 0.5% | $15.47 | $31.80 | — | COM | N5749R100 |
| — | AEGLEA BIO THERAPEUTICS INC | 3,004,959 | $1.352M | 0.5% | $0.45 | $1.46 | — | COM | 00773J103 |
| SVRA | SAVARA INC | 866,448 | $1.343M | 0.5% | $1.55 * | $1.21 | +13.1% | COM | 805111101 |
| IDYA | IDEAYA BIOSCIENCES INC | 70,000 | $1.272M | 0.5% | $18.17 * | $12.99 | +29.5% | COM | 45166A102 |
| TYRA | TYRA BIOSCIENCES INC | 152,159 | $1.156M | 0.4% | $7.60 * | $10.81 | -34.6% | COM | 90240B106 |
| — | MOLECULIN BIOTECH INC | 1,036,853 | $1.099M | 0.4% | $1.06 | $4.03 | — | COM | 60855D200 |
| VNDA | VANDA PHARMACEUTICALS INC | 136,325 | $1.007M | 0.4% | $7.39 * | $11.29 | -13.7% | COM | 921659108 |
| RLMD | RELMADA THERAPEUTICS INC | 235,600 | $822K | 0.3% | $3.49 * | $8.78 | 0.0% | Put | 75955J402 |
| RLMD | RELMADA THERAPEUTICS INC | 235,500 | $822K | 0.3% | $3.49 * | $8.78 | 0.0% | COM | 75955J402 |
| — | FUSION PHARMACEUTICALS INC | 260,448 | $820K | 0.3% | $3.15 | $11.22 | — | COM | 36118A100 |
| — | CONNECT BIOPHARMA HOLDINGS LTD | 597,678 | $519K | 0.2% | $0.87 | $3.02 | — | ADS | 207523101 |
| — | SIENTRA INC | 2,550,000 | $517K | 0.2% | $0.20 | $0.20 | — | COM | 82621J105 |
| — | ASLAN PHARMACEUTICALS LTD | 1,270,758 | $457K | 0.2% | $0.36 | $1.92 | — | ADS | 04522R101 |
| — | ELEVATION ONCOLOGY INC | 359,731 | $342K | 0.1% | $0.95 | $4.95 | — | COM | 28623U101 |
| — | NEXTCURE INC | 130,000 | $183K | 0.1% | $1.41 | $6.00 | — | COM | 65343E108 |
| — | CAREMAX INC | 43,549 | $119K | 0.0% | $2.73 | $8.24 | — | COM CL A | 14171W103 |
| — | VINCERX PHARMA INC | 102,049 | $104K | 0.0% | $1.02 | $18.89 | — | COM NEW | 92731L106 |
| NYXH | NYXOAH SA | 16,110 | $80,389 | 0.0% | $4.99 * | $31.50 | -81.9% | SHS | B6S7WD106 |
| HUMA | HUMACYTE INC | 49,998 | $20,314 | 0.0% | $0.41 * | $3.04 | 0.0% | *W EXP 08/27/202 | 44486Q103 |
| — | NEOLEUKIN THERAPEUTICS INC | 38,312 | $19,501 | 0.0% | $0.51 | $12.32 | — | COM | 64049K104 |